TP043/#1565 Phase II activity trial of high dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: groningen international study on sentinel nodes in vulvar cancer III (GROINSS-V III/NRG-GY024)
Publication
, Conference
Gien, L; Slomovitz, B; Leitao, M; Zee, AGVD; Creutzberg, C; Reyners, AK; Witteveen, P; Ayala-Peacock, D; Mayadev, J; Iii, CL; Oonk, M
Published in: E-Posters (Trials In Progress)
December 2022
Duke Scholars
Published In
E-Posters (Trials In Progress)
DOI
Publication Date
December 2022
Start / End Page
A244.1 / A244
Publisher
BMJ Publishing Group Ltd
Conference Name
IGCS 2022 Annual Meeting Abstracts
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Gien, L., Slomovitz, B., Leitao, M., Zee, A. G. V. D., Creutzberg, C., Reyners, A. K., … Oonk, M. (2022). TP043/#1565 Phase II activity trial of high dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: groningen international study on sentinel nodes in vulvar cancer III (GROINSS-V III/NRG-GY024). In E-Posters (Trials In Progress) (p. A244.1-A244). BMJ Publishing Group Ltd. https://doi.org/10.1136/ijgc-2022-igcs.552
Gien, Lilian, Brian Slomovitz, Mario Leitao, Ate Gj Van Der Zee, Carien Creutzberg, An Kl Reyners, Petronella Witteveen, et al. “TP043/#1565 Phase II activity trial of high dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: groningen international study on sentinel nodes in vulvar cancer III (GROINSS-V III/NRG-GY024).” In E-Posters (Trials In Progress), A244.1-A244. BMJ Publishing Group Ltd, 2022. https://doi.org/10.1136/ijgc-2022-igcs.552.
Gien L, Slomovitz B, Leitao M, Zee AGVD, Creutzberg C, Reyners AK, et al. TP043/#1565 Phase II activity trial of high dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: groningen international study on sentinel nodes in vulvar cancer III (GROINSS-V III/NRG-GY024). In: E-Posters (Trials In Progress). BMJ Publishing Group Ltd; 2022. p. A244.1-A244.
Gien, Lilian, et al. “TP043/#1565 Phase II activity trial of high dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: groningen international study on sentinel nodes in vulvar cancer III (GROINSS-V III/NRG-GY024).” E-Posters (Trials In Progress), BMJ Publishing Group Ltd, 2022, p. A244.1-A244. Crossref, doi:10.1136/ijgc-2022-igcs.552.
Gien L, Slomovitz B, Leitao M, Zee AGVD, Creutzberg C, Reyners AK, Witteveen P, Ayala-Peacock D, Mayadev J, Iii CL, Oonk M. TP043/#1565 Phase II activity trial of high dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: groningen international study on sentinel nodes in vulvar cancer III (GROINSS-V III/NRG-GY024). E-Posters (Trials In Progress). BMJ Publishing Group Ltd; 2022. p. A244.1-A244.
Published In
E-Posters (Trials In Progress)
DOI
Publication Date
December 2022
Start / End Page
A244.1 / A244
Publisher
BMJ Publishing Group Ltd
Conference Name
IGCS 2022 Annual Meeting Abstracts
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis